Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

15 May 2002

Gastric hyperemic response induced by acid back-diffusion in rat stomachs following barrier disruption - relation to vanilloid type-1 receptors.

Masato Nakashima, Shigeru Kagawa, Kimihito Tashima, Shinichi Kato, Koji Takeuchi

Med Sci Monit 2002; 8(5): BR157-163 :: ID: 420853

Abstract

BACKGROUND: Acid back-diffusion activates capsaicin-sensitive sensory neurons(CSN), leading to gastric hyperemic response. We examined the role of vanilloid type-1 receptor (VR1)in gastric hyperemic and ulcerogenic responses in rat stomach following exposure to taurocholate (TC).MATERIAL/METHODS: Under urethane anesthesia, a rat stomach was mounted on an ex-vivo chamber, perfusedwith 50 mM HCl, and changes in PD, gastric mucosal blood flow (GMBF), and luminal acid loss were measuredbefore and after exposure to 20 mM TC for 30 min, in presence of omeprazole. Capsazepine was co-appliedwith TC for 30 min to the stomach, while ruthenium red was given i.v. 10 min before TC treatment. RESULTS:TC caused a marked PD reduction, followed by an increase of acid loss and GMBF, resulting in minimaldamage in the mucosa. Chemical ablation of CSN attenuated the GMBF response to TC without affecting PDreduction and acid loss, and resulted in severe lesions, while none of these responses induced by TCwas significantly affected by either capsazepine or ruthenium red. Intragastric capsaicin increased GMBF,and this response was attenuated by both capsazepine and ruthenium red as well as sensory deafferentation.CONCLUSIONS: Both acid back-diffusion and capsaicin increase GMBF mediated by CSN, yet their modes ofaction differ in terms of capsazepine- or ruthenium red-sensitivity. Although the luminal H+ plays amodulator role for the physiological response mediated by CSN in the stomach, it is unlikely that theaction results from the interaction of H+ with the capsazepine- or ruthenium red-sensitive site of VR1.

Keywords: Capsaicin, Diffusion, Gastric Acid, Gastric Mucosa, Hydrogen, Receptors, Drug, Ruthenium Red, Stomach, stomach ulcer, Time Factors

Add Comment 0 Comments

512 3

Editorial

01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209

0:00

In Press

08 Jun 2023 : Clinical Research  

Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...

Med Sci Monit In Press; DOI: 10.12659/MSM.940134  

08 Jun 2023 : Clinical Research  

A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940124  

08 Jun 2023 : Clinical Research  

Burden of COVID-19 on Mental Health of Resident Doctors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940208  

08 Jun 2023 : Clinical Research  

Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...

Med Sci Monit In Press; DOI: 10.12659/MSM.940251  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750